|
US7861153B2
|
|
System and method for document construction
|
|
WO2005025669A2
|
|
Constant current electroporation device and methods of use
|
|
CA2575926A1
|
|
Canine specific growth hormone releasing hormone
|
|
TW200504207A
|
|
Devices and methods for biomaterial production
|
|
TW200424214A
|
|
Plasmid mediated GHRH supplementation for renal failures
|
|
WO2004081040A2
|
|
Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications
|
|
WO2004067719A2
|
|
Growth hormone releasing hormone (ghrh) for use in reducing culling in herd animals
|
|
MXPA05004860A
|
|
Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells.
|
|
TW200403338A
|
|
Codon optimized synthetic plasmids
|
|
WO03099341A1
|
|
Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system
|
|
US2004014645A1
|
|
Increased delivery of a nucleic acid construct in vivo by the poly-L-glutamate ("PLG") system
|
|
AU2003222254A1
|
|
Electrode assembly for constant-current electroporation and use
|
|
US2004057941A1
|
|
Treating anemia in subjects by administration of plasmids encoding growth hormone releasing hormone
|
|
US7245963B2
|
|
Electrode assembly for constant-current electroporation and use
|
